These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20576958)

  • 1. Monitoring and pharmacologic reversal of a nondepolarizing neuromuscular blockade should be routine.
    Miller RD; Ward TA
    Anesth Analg; 2010 Jul; 111(1):3-5. PubMed ID: 20576958
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monitoring of neuromuscular block and prevention of residual paralysis].
    Fuchs-Buder T; Meistelman C
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S46-50. PubMed ID: 19887277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of current management of neuromuscular block in the United States and Europe.
    Naguib M; Kopman AF; Lien CA; Hunter JM; Lopez A; Brull SJ
    Anesth Analg; 2010 Jul; 111(1):110-9. PubMed ID: 19910616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing neuromuscular block: where are the guidelines?
    Kopman AF
    Anesth Analg; 2010 Jul; 111(1):9-10. PubMed ID: 20576960
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sugammadex: a new approach to muscle relaxation and its reversal].
    Duvaldestin P
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S39-40. PubMed ID: 19887275
    [No Abstract]   [Full Text] [Related]  

  • 6. [Residual neuromuscular blockade].
    Beaussier M; Boughaba MA
    Ann Fr Anesth Reanim; 2005 Oct; 24(10):1266-74. PubMed ID: 16039822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular monitoring: what evidence do we need to be convinced?
    Donati F
    Anesth Analg; 2010 Jul; 111(1):6-8. PubMed ID: 20576959
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Erroneous attitudes in the use of neuromuscular blocking agents].
    Ortiz-Gómez JR
    Rev Esp Anestesiol Reanim; 2002 Feb; 49(2):65-8. PubMed ID: 12025249
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronary vasospasm during the reversal of neuromuscular block using neostigmine.
    Kido K; Mizuta K; Mizuta F; Yasuda M; Igari T; Takahashi M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1395-6. PubMed ID: 16146484
    [No Abstract]   [Full Text] [Related]  

  • 11. Residual neuromuscular blockade in myotonic dystrophy: lessons unlearned and sugammadex.
    Stewart PA; Phillips S; de Boer HD
    Anaesth Intensive Care; 2011 Jul; 39(4):756-7; author reply 757. PubMed ID: 21823393
    [No Abstract]   [Full Text] [Related]  

  • 12. Train-of-four: to use or not to use.
    Tschida SJ; Hoey LL; Mather D; Vance-Bryan K
    Pharmacotherapy; 1995; 15(4):546-50. PubMed ID: 7479212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular monitoring: old issues, new controversies.
    Kopman AF
    J Crit Care; 2009 Mar; 24(1):11-20. PubMed ID: 19272534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of a quality assurance program on the use of neuromuscular monitoring and reversal of muscle relaxants].
    Motamed C; Bourgain JL
    Ann Fr Anesth Reanim; 2009 Apr; 28(4):297-301. PubMed ID: 19304447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge of residual curarization: an Italian survey.
    Di Marco P; Della Rocca G; Iannuccelli F; Pompei L; Reale C; Pietropaoli P
    Acta Anaesthesiol Scand; 2010 Mar; 54(3):307-12. PubMed ID: 19839947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undetected residual neuromuscular block has consequences.
    Kopman AF
    Anesthesiology; 2008 Sep; 109(3):363-4. PubMed ID: 18719434
    [No Abstract]   [Full Text] [Related]  

  • 17. [Incidence and complications of post operative residual paralysis].
    Baillard C
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S41-5. PubMed ID: 19887276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness.
    Brull SJ; Murphy GS
    Anesth Analg; 2010 Jul; 111(1):129-40. PubMed ID: 20442261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prolonged neuromuscular blockade caused by mivacurium in a pediatric patient].
    Fernández-Rosado B; Vázquez-Fidalgo A; Pensado-Castiñeiras A; Figueira-Moure A; Rama-Maceiras P; Pose-Cambeiro P
    Rev Esp Anestesiol Reanim; 1999 Feb; 46(2):92. PubMed ID: 10100446
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence-based management of neuromuscular block.
    Viby-Mogensen J; Claudius C
    Anesth Analg; 2010 Jul; 111(1):1-2. PubMed ID: 20576957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.